SCHEMBL7816028

SCHEMBL7816028

CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NCC(O)CNS(=O)(=O)c1ccc(OOc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CA5A P35218 1/20 0.56
▸ CTSK P43235 15/20 0.56
▸ CTSS P25774 7/20 0.56
▸ CTSL P07711 3/20 0.56
▸ CTSB P07858 1/20 0.56
▸ CA1 P00915 1/20 0.53
▸ CAPN1 P07384 1/20 0.50
▸ CAPN2 P17655 1/20 0.50
▸ MMP13 P45452 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164038 0.95 CTSK (0.62) CA5ACTSKCTSSCTSLCTSB
SCHEMBL7165081 0.83 CTSK (0.51) CA5ACTSKCTSSCTSLCTSB
SCHEMBL7610538 0.82 CTSK (0.56) CA5ACTSKCTSSCTSLCTSB
SCHEMBL7815915 0.82 CTSK (0.55) CA5ACTSKCTSSCTSLCTSB
SCHEMBL5934588 0.81 CTSK (0.63) CA5ACTSKCTSSCTSLCTSB
SCHEMBL27575296 0.81 CTSK (0.69) CA5ACTSKCTSSCTSLCTSB
SCHEMBL27575295 0.81 CTSK (0.69) CA5ACTSKCTSSCTSLCTSB
SCHEMBL7167212 0.81 CTSK (0.69) CTSKCTSSCTSLCTSBCAPN1
SCHEMBL7611750 0.80 CTSK (0.67) CA5ACTSKCTSSCTSLCTSB
SCHEMBL7240364 0.80 CTSK (0.53) CA5ACTSKCTSSCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1068304-A4 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORP (US) 2001-05-09 — — EP disclosed
EP-1068304-A1 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORPORATION (US) 2001-01-17 — — EP disclosed
WO-1999053039-A1 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORPORATION (US) 1999-10-21 — — WO disclosed
Send feedback